Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 359

1.

Opportunistic pathogens and large microbial diversity detected in source-to-distribution drinking water of three remote communities in Northern Australia.

Kaestli M, O'Donnell M, Rose A, Webb JR, Mayo M, Currie BJ, Gibb K.

PLoS Negl Trop Dis. 2019 Sep 5;13(9):e0007672. doi: 10.1371/journal.pntd.0007672. eCollection 2019 Sep.

2.
3.

A cluster of melioidosis infections in hatchling saltwater crocodiles (Crocodylus porosus) resolved using genome-wide comparison of a common north Australian strain of Burkholderia pseudomallei.

Rachlin A, Kleinecke M, Kaestli M, Mayo M, Webb JR, Rigas V, Shilton C, Benedict S, Dyrting K, Currie BJ.

Microb Genom. 2019 Aug;5(8). doi: 10.1099/mgen.0.000288. Epub 2019 Aug 21.

4.

A general protein O-glycosylation machinery conserved in Burkholderia species improves bacterial fitness and elicits glycan immunogenicity in humans.

Fathy Mohamed Y, Scott NE, Molinaro A, Creuzenet C, Ortega X, Lertmemongkolchai G, Tunney MM, Green H, Jones AM, DeShazer D, Currie BJ, Foster LJ, Ingram R, De Castro C, Valvano MA.

J Biol Chem. 2019 Sep 6;294(36):13248-13268. doi: 10.1074/jbc.RA119.009671. Epub 2019 Jul 26.

PMID:
31350337
5.

Tracing the environmental footprint of the Burkholderia pseudomallei lipopolysaccharide genotypes in the tropical "Top End" of the Northern Territory, Australia.

Webb JR, Rachlin A, Rigas V, Sarovich DS, Price EP, Kaestli M, Ward LM, Mayo M, Currie BJ.

PLoS Negl Trop Dis. 2019 Jul 26;13(7):e0007369. doi: 10.1371/journal.pntd.0007369. eCollection 2019 Jul.

6.

Serological evidence of Burkholderia pseudomallei infection in U.S. Marines who trained in Australia from 2012-2014: a retrospective analysis of archived samples.

Schully KL, Burtnick MN, Bell MG, Spall A, Mayo M, Rigas V, Chan AA, Yu K, Clark DV, Maves RC, Currie BJ, Brett PJ, Lawler JV.

MSMR. 2019 Jul;26(7):8-17.

7.

Author Correction: Atlas of group A streptococcal vaccine candidates compiled using large-scale comparative genomics.

Davies MR, McIntyre L, Mutreja A, Lacey JA, Lees JA, Towers RJ, Duchêne S, Smeesters PR, Frost HR, Price DJ, Holden MTG, David S, Giffard PM, Worthing KA, Seale AC, Berkley JA, Harris SR, Rivera-Hernandez T, Berking O, Cork AJ, Torres RSLA, Lithgow T, Strugnell RA, Bergmann R, Nitsche-Schmitz P, Chhatwal GS, Bentley SD, Fraser JD, Moreland NJ, Carapetis JR, Steer AC, Parkhill J, Saul A, Williamson DA, Currie BJ, Tong SYC, Dougan G, Walker MJ.

Nat Genet. 2019 Aug;51(8):1295. doi: 10.1038/s41588-019-0482-z.

PMID:
31324894
8.

Chronic Pulmonary Melioidosis Masquerading as lung malignancy diagnosed by EBUS guided sheath technique.

Zaw KK, Wasgewatta SL, Kwong KK, Fielding D, Heraganahally SS, Currie BJ.

Respir Med Case Rep. 2019 Jun 29;28:100894. doi: 10.1016/j.rmcr.2019.100894. eCollection 2019.

9.

Whole-Genome Sequencing to Differentiate Relapse From Reinfection in Community-Onset Bacteremic Acinetobacter baumannii Pneumonia.

Meumann EM, Anstey NM, Currie BJ, Piera KA, Baird R, Sarovich DS, Davis JS.

Open Forum Infect Dis. 2019 Jun 1;6(7):ofz263. doi: 10.1093/ofid/ofz263. eCollection 2019 Jul.

10.

The global impact and cost-effectiveness of a melioidosis vaccine.

Luangasanatip N, Flasche S, Dance DAB, Limmathurotsakul D, Currie BJ, Mukhopadhyay C, Atkins T, Titball R, Jit M.

BMC Med. 2019 Jul 5;17(1):129. doi: 10.1186/s12916-019-1358-x.

11.

Concerns for efficacy of a 30-valent M-protein-based Streptococcus pyogenes vaccine in regions with high rates of rheumatic heart disease.

Giffard PM, Tong SYC, Holt DC, Ralph AP, Currie BJ.

PLoS Negl Trop Dis. 2019 Jul 3;13(7):e0007511. doi: 10.1371/journal.pntd.0007511. eCollection 2019 Jul.

12.

Atlas of group A streptococcal vaccine candidates compiled using large-scale comparative genomics.

Davies MR, McIntyre L, Mutreja A, Lacey JA, Lees JA, Towers RJ, Duchêne S, Smeesters PR, Frost HR, Price DJ, Holden MTG, David S, Giffard PM, Worthing KA, Seale AC, Berkley JA, Harris SR, Rivera-Hernandez T, Berking O, Cork AJ, Torres RSLA, Lithgow T, Strugnell RA, Bergmann R, Nitsche-Schmitz P, Chhatwal GS, Bentley SD, Fraser JD, Moreland NJ, Carapetis JR, Steer AC, Parkhill J, Saul A, Williamson DA, Currie BJ, Tong SYC, Dougan G, Walker MJ.

Nat Genet. 2019 Jun;51(6):1035-1043. doi: 10.1038/s41588-019-0417-8. Epub 2019 May 27. Erratum in: Nat Genet. 2019 Jul 19;:.

PMID:
31133745
13.

Pan-drug-resistant and biofilm-producing strain of Burkholderia pseudomallei: first report of melioidosis from a diabetic patient in Yogyakarta, Indonesia [Letter].

Dance DA, Wuthiekanun V, Sarovich D, Price EP, Limmathurotsakul D, Currie BJ, Trung TT.

Int Med Case Rep J. 2019 Apr 18;12:117-118. doi: 10.2147/IMCRJ.S205245. eCollection 2019. No abstract available.

14.

Arboviral diseases and malaria in Australia, 2014–15: Annual report of the National Arbovirus and Malaria Advisory Committee

Knope K, Doggett SL, Jansen CC, Johansen CA, Kurucz N, Feldman R, Lynch SE, Hobby MP, Sly A, Jardine A, Bennett S, Currie BJ, the National Arbovirus and Malaria Advisory Committee.

Commun Dis Intell (2018). 2019 Apr 15;43. doi: 10.33321/cdi.2019.43.14.

15.

Burkholderia pseudomallei Lipopolysaccharide Genotype Does Not Correlate With Severity or Outcome in Melioidosis: Host Risk Factors Remain the Critical Determinant.

Webb JR, Sarovich DS, Price EP, Ward LM, Mayo M, Currie BJ.

Open Forum Infect Dis. 2019 Feb 25;6(4):ofz091. doi: 10.1093/ofid/ofz091. eCollection 2019 Apr.

16.

Clinical Utility of Platelet Count as a Prognostic Marker for Melioidosis.

Kirby P, Smith S, Ward L, Hanson J, Currie BJ.

Am J Trop Med Hyg. 2019 May;100(5):1085-1087. doi: 10.4269/ajtmh.18-0698.

PMID:
30887945
17.

Melioidosis: The hazards of incomplete peer-review.

Limmathurotsakul D, Daily F, Bory S, Khim G, Wiersinga WJ, Torres AG, Dance DAB, Currie BJ.

PLoS Negl Trop Dis. 2019 Mar 14;13(3):e0007123. doi: 10.1371/journal.pntd.0007123. eCollection 2019 Mar. No abstract available.

18.

Caprine humoral response to Burkholderia pseudomallei antigens during acute melioidosis from aerosol exposure.

Yi J, Simpanya MF, Settles EW, Shannon AB, Hernandez K, Pristo L, Keener ME, Hornstra H, Busch JD, Soffler C, Brett PJ, Currie BJ, Bowen RA, Tuanyok A, Keim P.

PLoS Negl Trop Dis. 2019 Feb 27;13(2):e0006851. doi: 10.1371/journal.pntd.0006851. eCollection 2019 Feb.

19.

Genomic epidemiology of severe community-onset Acinetobacter baumannii infection.

Meumann EM, Anstey NM, Currie BJ, Piera KA, Kenyon JJ, Hall RM, Davis JS, Sarovich DS.

Microb Genom. 2019 Mar;5(3). doi: 10.1099/mgen.0.000258. Epub 2019 Feb 26.

20.

Treatment, prevention and public health management of impetigo, scabies, crusted scabies and fungal skin infections in endemic populations: a systematic review.

May PJ, Tong SYC, Steer AC, Currie BJ, Andrews RM, Carapetis JR, Bowen AC.

Trop Med Int Health. 2019 Mar;24(3):280-293. doi: 10.1111/tmi.13198. Epub 2019 Jan 28.

Supplemental Content

Loading ...
Support Center